Becca Carlson is Co-Founder and Co-CEO of Deliverome Bio, a nonprofit focused research organization building open datasets of human cell surface protein abundance, internalization, and trafficking to address the delivery bottleneck in precision medicines. Funded by the Astera Institute and Renaissance Philanthropy, Deliverome operates as a Focused Research Organization, releasing its data continuously rather than at publication. Becca came to Deliverome from Flagship Pioneering, where she originated and developed new biotechnology ventures. Her work has consistently centered on building measurement platforms that turn difficult cell biology into large, usable datasets. She earned her PhD in MIT’s Health Sciences & Technology program as a Hertz Fellow, with research at the Broad Institute, where she helped develop optical pooled screening and led the first genome-wide optical pooled screen at million-cell scale, spanning membrane trafficking and innate immune signaling.
Deliverome Bio is a nonprofit research organization mapping surface protein abundance and internalization across the human surfaceome to identify new targets for precision delivery of biologic therapeutics. Doing so first requires a reliable list of surface proteins, yet the five most widely used databases collectively identify 5,546 proteins and agree on only 188. We developed an agentic LLM pipeline that classifies candidates using full-text scientific literature, yielding an open, evidence-linked atlas of the accessible human surfaceome that includes 1,108 candidates absent from all five databases. The atlas and its underlying literature evidence are publicly accessible through our interactive viewer (surfaceome.deliverome.org) and API. We are building on this resource with systematic ORF-based screens of surface protein abundance and internalization, alongside surface proteomics in primary cells and tissues, to enable data-driven discovery and prioritization of receptors for precision delivery.